This site is intended for healthcare professionals only

Diabetes &
Primary Care

Issue:

Share this article

Diabetes Distilled: Intensive intervention reduces stroke risk in diabetes with microalbuminuria

Colin Kenny
Data from the Steno-2 Study were analysed to assess whether multiple risk factor intervention reduced the chance of stroke in individuals with type 2 diabetes and microalbuminuria. Participants were randomly allocated to intensified or conventional multifactorial intervention targeting classical cardiovascular disease risk factors. Post hoc analysis showed that the risk of stroke and number of recurrent cerebrovascular events were reduced with intensified multiple risk factor intervention in patients with type 2 diabetes and microalbuminuria.

By Colin Kenny, Editor – Diabetes Distilled

Data from the Steno-2 Study were analysed to assess whether multiple risk factor intervention reduced the chance of stroke in individuals with type 2 diabetes and microalbuminuria. Participants were randomly allocated to intensified or conventional multifactorial intervention targeting classical cardiovascular disease risk factors. Post hoc analysis showed that the risk of stroke and number of recurrent cerebrovascular events were reduced with intensified multiple risk factor intervention in patients with type 2 diabetes and microalbuminuria.

Stroke events are more common in individuals with diabetes. Investigators examined data from the Steno-2 Study to examine the difference in time to first stroke event between the intensive and conventional treatment groups.

A total of 160 participants with type 2 diabetes and microalbuminuria randomised to conventional or intensified multiple risk factor intervention targeting several concomitant risk factors were followed up for 22.2 years. Thirty participants had experienced a total of 39 stroke events during this period. Individuals that had received conventional therapy were more likely to experience this outcome.

The investigators concluded that the hazard for first stroke after randomisation was reduced by 69% and the absolute risk by 15% with intensive therapy versus conventional treatment. Similarly, individuals originally randomised to conventional treatment were significantly more likely to have recurrent strokes than those allocated to intensified therapy.

To access the publication, click here  

Related content
Editorial: Updated guidance on prescribing incretin-based therapy, cardiovascular risk reduction and the wider uptake of CGM
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.